Protective Effects of Follicle-stimulating Hormone Inhibitor on Alveolar Bone Loss Resulting from Experimental Periapical Lesions in Ovariectomized Rats
Authors:
- Zhuan BianZBZhuan Bian
- 1 April 2010
- journal article
- Published by Elsevier in Journal of Endodontics
- Vol. 36 (4) , 658-663
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (30670115)
This publication has 23 references indexed in Scilit:
- FSH Aggravates Periodontitis-related Bone Loss in Ovariectomized RatsJournal of Dental Research, 2010
- Proresorptive Actions of FSH and Bone LossAnnals of the New York Academy of Sciences, 2007
- FSH and bone – important physiology or not?Trends in Molecular Medicine, 2007
- Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formationProceedings of the National Academy of Sciences, 2006
- Estrogen and alendronate therapies may prevent the influence of estrogen deficiency on the tooth‐supporting alveolar bone: a histometric study in ratsJournal of Periodontal Research, 2006
- Bone loss goes beyond estrogenNature Medicine, 2006
- Expressions of Nuclear Factor κB, Inducible Nitric Oxide Synthase, and Vascular Endothelial Growth Factor in Adenoid Cystic Carcinoma of Salivary Glands: Correlations with the Angiogenesis and Clinical OutcomeClinical Cancer Research, 2005
- Pamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate CancerNew England Journal of Medicine, 2001
- Effect of interleukin-6 deficiency on the formation of periapical lesions after pulp exposure in miceOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2001
- Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast functionCalcified Tissue International, 1982